What does PHARMACIE DROULEZ do?

PHARMACIE DROULEZ is a pharmacy in Jurbise. Private Limited, started on 22 February 2010, 1 establishment.

What is the address of PHARMACIE DROULEZ?

The registered office of PHARMACIE DROULEZ is located at Place d'Herchies(H) 14, 7050 Jurbise.

Is PHARMACIE DROULEZ still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DROULEZ is active, legal situation “Normale toestand”, started on 22 February 2010.

Is PHARMACIE DROULEZ registered on Peppol?

Yes, PHARMACIE DROULEZ is registered on the Peppol network with ID 0208:0823341344.

What is the enterprise number of PHARMACIE DROULEZ?

The enterprise number of PHARMACIE DROULEZ is BE0823341344.

When was PHARMACIE DROULEZ founded?

PHARMACIE DROULEZ was founded on 22 February 2010.

Who are the directors of PHARMACIE DROULEZ?

According to the 2025 annual accounts, the directors of PHARMACIE DROULEZ are: François Victor Droulez, ISABELLE DERNICOURT.

Is PHARMACIE DROULEZ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 February 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DROULEZ make in 2025?

PHARMACIE DROULEZ posted a profit after taxes of € 81,368 in financial year 2025.

What is the revenue of PHARMACIE DROULEZ?

As a small company, PHARMACIE DROULEZ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 130,997.

PHARMACIE DROULEZ (Private Limited) - Jurbise

Dossier PHARMACIE DROULEZ, printed on 30 October 2026 from databakkes.be/en/0823341344/pharmacie-droulez. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DROULEZ from Jurbise, company number BE0823341344, closed financial year 2025 with a result of € 81,368 after tax. For that financial year PHARMACIE DROULEZ recorded a gross margin of € 130,997 and equity of € 306,787. Compared with financial year 2024, the result moved from € 40,253 to € 81,368. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Healthy

€ 306,787

▼ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 81,368

▲ 102% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 220,898

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 170,003 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,649

▲ € 3,015 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 28,757

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,724

▲ 231% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 137,841 Gross margin 2022: € 137,841 First fiscal year in the series	€ 125,374 Gross margin 2023: € 125,374 ▼ 9% vs 2022 (€ 137,841) Unfavourable step	€ 97,048 Gross margin 2024: € 97,048 ▼ 23% vs 2023 (€ 125,374) Unfavourable step	€ 130,997 Gross margin 2025: € 130,997 ▲ 35% vs 2024 (€ 97,048) Favourable step	▲ 35%
Profit after taxes	€ 77,300 Profit after taxes 2022: € 77,300 First fiscal year in the series	€ 68,823 Profit after taxes 2023: € 68,823 ▼ 11% vs 2022 (€ 77,300) Unfavourable step	€ 40,253 Profit after taxes 2024: € 40,253 ▼ 42% vs 2023 (€ 68,823) Unfavourable step	€ 81,368 Profit after taxes 2025: € 81,368 ▲ 102% vs 2024 (€ 40,253) Favourable step	▲ 102%
Equity	€ 356,665 Equity 2022: € 356,665 First fiscal year in the series	€ 396,355 Equity 2023: € 396,355 ▲ 11% vs 2022 (€ 356,665) Favourable step	€ 395,422 Equity 2024: € 395,422 Unchanged (€ 396,355) Unfavourable step	€ 306,787 Equity 2025: € 306,787 ▼ 22% vs 2024 (€ 395,422) Unfavourable step	▼ 22%
Total debts	€ 111,346 Total debts 2022: € 111,346 First fiscal year in the series	€ 60,833 Total debts 2023: € 60,833 ▼ 45% vs 2022 (€ 111,346) Favourable step	€ 77,462 Total debts 2024: € 77,462 ▲ 27% vs 2023 (€ 60,833) Unfavourable step	€ 215,485 Total debts 2025: € 215,485 ▲ 178% vs 2024 (€ 77,462) Unfavourable step	▲ 178%
Cash	€ 248,052 Cash 2022: € 248,052 First fiscal year in the series	€ 233,609 Cash 2023: € 233,609 ▼ 6% vs 2022 (€ 248,052) Unfavourable step	€ 277,557 Cash 2024: € 277,557 ▲ 19% vs 2023 (€ 233,609) Favourable step	€ 220,898 Cash 2025: € 220,898 ▼ 20% vs 2024 (€ 277,557) Unfavourable step	▼ 20%
Land & buildings	€ 31,250 Land & buildings 2022: € 31,250 First fiscal year in the series	€ 16,250 Land & buildings 2023: € 16,250 ▼ 48% vs 2022 (€ 31,250) Unchanged	€ 0 Land & buildings 2024: € 0 ▼ 100% vs 2023 (€ 16,250) Unchanged	-
Retained profit	€ 350,465 Retained profit 2022: € 350,465 First fiscal year in the series	€ 390,155 Retained profit 2023: € 390,155 ▲ 11% vs 2022 (€ 350,465) Favourable step	€ 389,222 Retained profit 2024: € 389,222 Unchanged (€ 390,155) Unfavourable step	€ 300,587 Retained profit 2025: € 300,587 ▼ 23% vs 2024 (€ 389,222) Unfavourable step	▼ 23%
Dividend	€ 70,722 Dividend 2022: € 70,722 First fiscal year in the series	€ 29,134 Dividend 2023: € 29,134 ▼ 59% vs 2022 (€ 70,722) Unchanged	€ 41,186 Dividend 2024: € 41,186 ▲ 41% vs 2023 (€ 29,134) Unchanged	€ 170,003 Dividend 2025: € 170,003 ▲ € 128,818 vs 2024 (€ 41,186) Unchanged	▲ € 128,818
Balance sheet total	€ 468,011 Balance sheet total 2022: € 468,011 First fiscal year in the series	€ 457,187 Balance sheet total 2023: € 457,187 ▼ 2% vs 2022 (€ 468,011) Unchanged	€ 472,884 Balance sheet total 2024: € 472,884 ▲ 3% vs 2023 (€ 457,187) Unchanged	€ 522,272 Balance sheet total 2025: € 522,272 ▲ 10% vs 2024 (€ 472,884) Unchanged	▲ 10%

Key figures of PHARMACIE DROULEZ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DROULEZ?

What happened at PHARMACIE DROULEZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 81,368 (▲ 102% vs 2024). Source: NBB ↗
2023 François Victor Droulez became a director. NBB
2023 ISABELLE DERNICOURT became a director. NBB
Feb 22, 2010 New establishment in Jurbise. KBO
Feb 22, 2010 Start of the company according to the CBE. KBO

In short

From € 77,300 profit in 2022 to € 81,368 profit in 2025.

Paid € 122,558 in corporate taxes since 2022.

Best year ever: 2025, with € 81,368 profit.

Paid out € 311,044 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

François Victor Droulez ISABELLE DERNICOURT

PHARMACIE DROULEZ

Behind PHARMACIE DROULEZ are François Victor Droulez and ISABELLE DERNICOURT.

Directors

According to the 2025 annual accounts

François Victor Droulez

Director

since 2023

ISABELLE DERNICOURT

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Place d'Herchies(H) 14

7050 Jurbise

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0823.341.344
VAT number: BE 0823.341.344
Registered office: Place d'Herchies(H) 14, 7050 Jurbise
Names & denominations: PHARMACIE DROULEZ
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 February 2010
Peppol: Active · Active since 6 Oct 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗